| Current treatment strategies for advanced prostate cancer K Komura, CJ Sweeney, T Inamoto, N Ibuki, H Azuma, PW Kantoff International Journal of Urology 25 (3), 220-231, 2018 | 223 | 2018 |
| Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression K Komura, SH Jeong, K Hinohara, F Qu, X Wang, M Hiraki, H Azuma, ... Proceedings of the National Academy of Sciences 113 (22), 6259-6264, 2016 | 140 | 2016 |
| A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2) YZ Mazzu, J Armenia, G Chakraborty, Y Yoshikawa, SAA Coggins, ... Clinical Cancer Research 25 (14), 4480-4492, 2019 | 115 | 2019 |
| Association of AR-V7 and prostate-specific antigen RNA levels in blood with efficacy of abiraterone acetate and enzalutamide treatment in men with prostate cancer F Qu, W Xie, M Nakabayashi, H Zhang, SH Jeong, X Wang, K Komura, ... Clinical cancer research 23 (3), 726-734, 2017 | 113 | 2017 |
| Incidence of urethral stricture after bipolar transurethral resection of the prostate using TUR is: Results from a randomised trial K Komura, T Inamoto, T Takai, T Uchimoto, K Saito, N Tanda, K Minami, ... BJU international 115 (4), 644-652, 2015 | 99 | 2015 |
| microRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer K Takahara, M Ii, T Inamoto, T Nakagawa, N Ibuki, Y Yoshikawa, T Tsujino, ... Stem cells and development 25 (17), 1290-1298, 2016 | 93 | 2016 |
| Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression G Chakraborty, J Armenia, YZ Mazzu, S Nandakumar, KH Stopsack, ... Clinical Cancer Research 26 (8), 2047-2064, 2020 | 92 | 2020 |
| SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells Y Kuranaga, N Sugito, H Shinohara, T Tsujino, K Taniguchi, K Komura, ... International journal of molecular sciences 19 (10), 3012, 2018 | 90 | 2018 |
| ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D K Komura, Y Yoshikawa, T Shimamura, G Chakraborty, TA Gerke, ... The Journal of clinical investigation 128 (7), 2979-2995, 2018 | 58 | 2018 |
| Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis K Takahara, M Ii, T Inamoto, K Komura, N Ibuki, K Minami, H Uehara, ... Biochemical and biophysical research communications 446 (4), 1102-1107, 2014 | 57 | 2014 |
| MUC1-C activates BMI1 in human cancer cells M Hiraki, T Maeda, A Bouillez, M Alam, A Tagde, K Hinohara, Y Suzuki, ... Oncogene 36 (20), 2791-2801, 2017 | 50 | 2017 |
| A panel of microRNA signature as a tool for predicting survival of patients with urothelial carcinoma of the bladder T Inamoto, H Uehara, Y Akao, N Ibuki, K Komura, K Takahara, T Takai, ... Disease markers 2018, 2018 | 45 | 2018 |
| Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer T Sun, SY Du, J Armenia, F Qu, J Fan, X Wang, T Fei, K Komura, SX Liu, ... Oncogenesis 7 (3), 30, 2018 | 42 | 2018 |
| C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma–A data from multi-institutional study in Japan T Tsujino, K Komura, T Hashimoto, R Muraoka, N Satake, T Matsunaga, ... Urologic Oncology: Seminars and Original Investigations 37 (11), 812. e1-812. e8, 2019 | 39 | 2019 |
| Comparative lipidomics of 5-Fluorouracil–sensitive and–resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1) JH Jung, K Taniguchi, HM Lee, MY Lee, R Bandu, K Komura, KY Lee, ... Scientific Reports 10 (1), 6124, 2020 | 33 | 2020 |
| MicroRNA‐143/Musashi‐2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer T Tsujino, N Sugito, K Taniguchi, R Honda, K Komura, Y Yoshikawa, ... Cancer Science 110 (7), 2189-2199, 2019 | 32 | 2019 |
| Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft T Inamoto, K Taniguchi, K Takahara, A Iwatsuki, T Takai, K Komura, ... Oncotarget 6 (25), 21628, 2015 | 30 | 2015 |
| Preoperative measurement of the modified glasgow prognostic score predicts patient survival in non-metastatic renal cell carcinoma prior to nephrectomy T Tsujino, K Komura, T Matsunaga, Y Yoshikawa, T Takai, T Uchimoto, ... Annals of surgical oncology 24, 2787-2793, 2017 | 29 | 2017 |
| Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma K Komura, T Inamoto, PC Black, K Koyama, Y Katsuoka, T Watsuji, ... Nutrition and cancer 63 (6), 908-915, 2011 | 29 | 2011 |
| The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma T Tsujino, K Komura, A Ichihashi, T Tsutsumi, T Matsunaga, Y Yoshikawa, ... Oncotarget 8 (66), 110311, 2017 | 28 | 2017 |
